Editas Medicine, Inc.
EDIT
$1.28
$0.010.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 269.91M | 265.09M | 279.11M | 296.17M | 323.11M |
| Total Receivables | 16.27M | 126.00K | 244.00K | 245.00K | 10.19M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.14M | 5.93M | 7.00M | 9.14M | 7.53M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 289.32M | 271.14M | 286.35M | 305.56M | 340.83M |
|
|
|||||
| Total Current Assets | 289.32M | 271.14M | 286.35M | 305.56M | 340.83M |
| Net Property, Plant & Equipment | 47.05M | 51.15M | 51.11M | 44.70M | 45.71M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.22M | 5.28M | 8.15M | 9.49M | 8.59M |
| Total Assets | 341.59M | 327.57M | 384.80M | 440.35M | 499.15M |
|
|
|||||
| Total Accounts Payable | 5.49M | 12.49M | 13.77M | 7.97M | 8.27M |
| Total Accrued Expenses | 44.10M | 28.79M | 27.67M | 31.48M | 34.56M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.65M | 16.39M | 18.18M | 12.36M | 12.16M |
| Total Finance Division Other Current Liabilities | 12.98M | 14.68M | 14.68M | 14.68M | 8.22M |
| Total Other Current Liabilities | 12.98M | 14.68M | 14.68M | 14.68M | 8.22M |
| Total Current Liabilities | 77.23M | 72.35M | 74.31M | 66.49M | 63.22M |
|
|
|||||
| Total Current Liabilities | 77.23M | 72.35M | 74.31M | 66.49M | 63.22M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 20.38M | 22.10M | 20.51M | 21.78M | 24.37M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 109.71M | 57.49M | 57.97M | 57.68M | 62.47M |
| Total Liabilities | 207.32M | 151.93M | 152.79M | 145.95M | 150.06M |
|
|
|||||
| Common Stock & APIC | 1.60B | 1.60B | 1.59B | 1.59B | 1.58B |
| Retained Earnings | -1.47B | -1.42B | -1.36B | -1.29B | -1.23B |
| Treasury Stock & Other | 268.00K | 522.00K | -442.00K | -326.00K | 198.00K |
| Total Common Equity | 134.27M | 175.63M | 232.01M | 294.40M | 349.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 134.27M | 175.63M | 232.01M | 294.40M | 349.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 134.27M | 175.63M | 232.01M | 294.40M | 349.10M |
|
|
|||||